Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 62 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
JUDILU MEDICAL from Ukkel, company number BE0745480038, closed financial year 2025 with a result of € 149,462 after tax. For that financial year JUDILU MEDICAL recorded a gross margin of € 201,636 and equity of € 77,310. Compared with financial year 2024, the result moved from € 114,473 to € 149,462. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.
€ 77,310
▼ 17% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 149,462
▲ 31% vs 2024
Profit after tax over the fiscal year.
€ 115,236
▲ 215% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 165,426 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 59
▼ 60% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 34,198
▲ 42% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 124,670 | € 160,056 | € 153,188 | € 201,636 | ▲ 32% |
| Profit after taxes | € 88,427 | € 116,645 | € 114,473 | € 149,462 | ▲ 31% |
| Equity | € 93,701 | € 93,274 | € 93,274 | € 77,310 | ▼ 17% |
| Total debts | € 144,112 | € 150,505 | € 142,289 | € 185,377 | ▲ 30% |
| Cash | € 91,122 | € 31,647 | € 36,607 | € 115,236 | ▲ 215% |
| Retained profit | € 88,701 | € 88,274 | € 88,274 | € 72,310 | ▼ 18% |
| Dividend | € 88,000 | € 117,072 | € 114,473 | € 165,426 | ▲ 45% |
| Bank debt | € 27,699 | € 18,292 | € 8,792 | € 0 | ▼ 100% |
| Balance sheet total | € 237,812 | € 243,778 | € 235,563 | € 262,687 | ▲ 12% |
Key figures of JUDILU MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to JUDILU MEDICAL?
What happened at JUDILU MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 149,462 (▲ 31% vs 2024). Source: NBB ↗
- New establishment in Ukkel. KBO
- New establishment in Linkebeek. KBO
- OLIVIER MAURY became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 88,427 profit in 2022 to € 149,462 profit in 2025.
Paid € 135,060 in corporate taxes since 2022.
Best year ever: 2025, with € 149,462 profit.
Paid out € 484,971 in dividends to the owners in total.
A new publication or filing at JUDILU MEDICAL? We notify you, reason included.
Follow JUDILU MEDICALDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind JUDILU MEDICAL is OLIVIER MAURY. The shares are held by OLIVIER MAURY (100%). It owns 33.3% of MEDILINK-MEDICALE itself.
Directors
According to the 2025 annual accounts
OLIVIER MAURY
Director
Owns 100% directly
since 2020
Shareholders
OLIVIER MAURY · director
100%
Participations
33.3%
Establishments
Establishment units
Physical locations of this company
Verrewinkelstraat 28
1180 Ukkel
Engelandstraat 38
1180 Ukkel
Active since 17 March 2020
Stationsstraat 78
1630 Linkebeek
Active since 17 March 2020
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0745.480.038
- VAT number
- BE 0745.480.038
- Registered office
- Verrewinkelstraat 28, 1180 Ukkel
- Names & denominations
- JUDILU MEDICAL · JUDILU
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 March 2020
- Peppol
- Not registered